Schering-Plough reported that the FDA has approved a new scent-free formulation of Nasonex
prescription nasal inhaled steroid. Nasonex remains the first and only once-daily prescription nasal
inhaled steroid approved to help prevent most seasonal nasal allergy symptoms, including nasal congestion,
in adults and children 12 years of age and older and the only nasal inhaled steroid approved to treat
nasal allergy symptoms, including nasal congestion, in patients as young as 2 years of age.